FDAnews
www.fdanews.com/articles/101826-gsk-acquires-rights-to-santarus-omeprazole-products

GSK Acquires Rights to Santarus Omeprazole Products

December 5, 2007
Santarus has entered into agreements granting exclusive rights to GlaxoSmithKline to commercialize prescription and over-the-counter immediate-release omeprazole products for a number of markets in GSK’s international region and to distribute and sell Zegerid brand prescription products in Puerto Rico and the U.S. Virgin Islands.
Pharmaceutical Business Review